Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2009
12/03/2009WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009US20090299077 Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
12/03/2009US20090299076 Axially asymmetric ester compound and production method thereof
12/03/2009US20090299058 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/03/2009US20090298900 Oxo-Imidazolyl Compounds
12/03/2009US20090298897 Treatment of Inflammatory Disorders With Triazole Compounds
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009US20090298835 Novel scaffolds for alpha-helix mimicry
12/03/2009US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
12/03/2009US20090298811 Benzimidazolone derivatives
12/03/2009US20090297473 Sulphonylpyrrole Hydrochloride Salts as Histone Deacetylases Inhibitors
12/03/2009US20090295274 Deuterated Semiconducting Organic Compounds for Use in Light-Emitting Devices
12/03/2009CA2725563A1 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof
12/03/2009CA2725111A1 Substituted carbinol compound having a cyclic linker
12/03/2009CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/02/2009EP2128138A1 Pyrazole compound
12/02/2009EP2127652A1 Method for treating cancer using anticancer agent in combination
12/02/2009EP2125776A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP2125731A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/02/2009EP2125720A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
12/02/2009EP2124560A1 2-aminopyrimidine modulators of the histamine h4 receptor
12/02/2009EP1664029B1 Quinazoline derivatives as antitumor agents
12/02/2009EP1646636B1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
12/02/2009EP1606284B1 Compositions useful as protein kinase inhibitors
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009CN101595104A Novel crystalline compound useful as GLK activator
12/02/2009CN101595103A Pyrimidine derivatives
12/02/2009CN101595084A Biaryl compositions and methods for modulating a kinase cascade
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591295A Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols
12/01/2009US7626040 Substituted imidazole compounds as KSP inhibitors
12/01/2009US7626026 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
12/01/2009US7625938 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625931 Certain substituted diphenyl ureas, as modulators of kinase activity
12/01/2009US7625915 treating colon cancer comprising administering N-(1-(4-Methoxyphenyl)-3-tert-butyl-5-pyrazolyl)-N'-(2,3-dichlorophenyl)urea; antitumor, anticarcinogenic, antiproliferative agent; ras protein signal transduction cascade related cancer
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009US7625904 Methods for the treatment of sleep disorders
12/01/2009US7625903 Anticancer agent; N-(1-methylethyl)-2-[(5-methyl-2-{[3-(4-methyl-2-oxo-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)amino]benzamide
12/01/2009US7625902 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one
12/01/2009US7625880 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease
12/01/2009CA2461100C 4-imidazolin-2-one compounds
11/2009
11/26/2009WO2009143507A2 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009143039A2 Heterocyclic compounds as factor ixa inhibitors
11/26/2009WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009WO2009142771A2 Salts of (r)-5-(2-phenylsulphonylethenyl)-3-(n- methylpyrrolidin-2-ylmethyl)-1h-indole, 5-bromo-3-[(r)-1- methyl-pyrrolidin-2- ylmethyl]-1h-indole and of eletriptan
11/26/2009WO2009142732A2 Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009141386A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009WO2009141292A1 Substituted heteroarylmethyl sulfonamides
11/26/2009WO2009140928A1 Dihydroindolinone derivatives
11/26/2009WO2009111028A8 Aurora kinase inhibitors
11/26/2009WO2008115516A8 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
11/26/2009US20090292105 Sulphonyl-1,2,4-triazole salts
11/26/2009US20090291974 Bosentan salts
11/26/2009US20090291965 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291962 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor
11/26/2009US20090291960 Pyrrolinidium derivatives as m3 muscarinic receptors
11/26/2009US20090291957 Heterocyclic derivatives and their use as therapeutic agents
11/26/2009US20090291948 Sulfonamide peri-substituted bicyclics for occlusive artery disease
11/26/2009US20090291940 Aminopyrrolidine compound
11/26/2009US20090291903 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009US20090288707 Novel compounds for electronic material and organic electronic device using the same
11/26/2009CA2725185A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009CA2725045A1 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009CA2725001A1 Dihydroindolone derivatives
11/26/2009CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009CA2724430A1 Heterocyclic compounds as factor ixa inhibitors
11/25/2009EP2123649A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
11/25/2009EP2123648A1 A process for the preparation of Telmisartan.
11/25/2009EP2123647A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases
11/25/2009EP2121659A1 Modulators of cb1 receptors
11/25/2009EP2121658A2 Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same
11/25/2009EP2121657A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
11/25/2009EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009EP2121617A1 Cb1 receptor modulators
11/25/2009EP2121600A2 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP2120578A1 Kinase inhibitor compounds
11/25/2009EP1853591B1 Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1765335B1 Pyrazole amide derivatives, compositions containing such compounds and methods of use
11/25/2009EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009CN101589036A Aminopyrimidines useful as inhibitors of protein kinases
11/25/2009CN101589024A Novel minor groove binders
11/25/2009CN101585831A Synthetic method of ramosetron
11/25/2009CN101584691A Compounds effecting glucokinase
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 626